DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company’s official interface for regulatory interactions within the EU, the office will operate as DOR BioPharma UK Ltd. and will be located at: BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire.     “The new DOR UK office gives us a multinatio...